Web-Verzeichnis
über 62.000 Links
Jobbörse
aktuelle Gesuche / Angebote
Termine
Messe, Kongreße, Seminare
Produkte
aktuelle Produktinformationen
Unternehmen
25045 Firmeneinträge
Fachbeiträge
detailierte Fachinformationen
News
aktuelle Industrienachrichten

Neurotrophic Keratitis Market demonstrates a spectacular growth by 2027 according to new research report

ID: 1728561
The global neurotrophic keratitis market is expected to expand at a CAGR of 5.2% from 2019 to 2027.

(industrietreff) - The latest market report published by Credence Research, Inc. “Global neurotrophic keratitis Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global neurotrophic keratitis market is expected to expand at a CAGR of 5.2% from 2019 to 2027.
Market Insights
Ophthalmologist are currently employing the healing pathway of nerve growth factor (NGF) which is a neurotrophin that initiates neuronal sprouting by injured and intact neurons, a landmark discovery made by R. Levi Montalcini a nobel laureate. The human cornea produces high affinity NGF receptors which plays an important role in stimulating both survival and proliferation of epithelial and nerve fibres. Oxervate follows this pathway to treat neurotrophic keratitis across all age group.
Neurotrophic keratitis is an orphan disease with a global prevalence rate of 5 per 10,000 people. It is manifested by the damage of trigeminal nucleus nerve innervations present in the eye corneal region which dampens the healing process of corneal injuries. The treatment approach is adopted as per the different stages of the disease. Artificial tears are recommended in all the phases to ensure wetness, cleanliness and lubrication of the corneal surface. Topical antibiotics are prescribed in the stage 2 of the disease as a preventive measure against bacterial infection. In stage 3 surgical procedures such as Tarsorraphy, and amniotic membrane transplantation are preferred to treat corneal ulcers. Recent approval of Oxervate a recombinant human nerve growth factor by EMA and USFDA will bolster the neurotrophic market growth during the forecast period.

North America is responsible for 33% market share and is currently the largest regional segment in neurotrophic keratitis market. As per the research findings brought forward by the American Academy of Ophthalmology (AAO), approximately 65,000 U.S. citizens are reported to be suffering with neurotrophic keratitis. Affordable reimbursement scenario propels the neurotrophic keratitis market growth in North America region. Europe trails North America and accounts for 28.5% market growth primarily due to strategic collaboration between academic research institute and pharmaceutical giants to develop novel drugs for the treatment of neurotrophic keratitis. European Medical Agency (EMA) has awarded orphan disease status to neurotrophic keratitis and has expedited its drug development and sale propaganda in the EU market. Asia Pacific holds 16% market share owing to the rising prevalence of neurotrophic keratitis in geriatric population and rampant growth in ophthalmology in the region over the last decade.





Pharmaceutical companies specializing in providing medication for the treatment of neurotrophic keratitis are Allergan, Plc., Abbott Laboratories, Inc., Bausch & Lomb Incorporated, Bayer AG, CooperVision, Dompe farmaceutici S.p.A., Johnson & Johnson, Novartis AG, ReGenTree, LLC., and Walgreens.
Key Market Movements:
•Rising prevalence of neurotrophic keratitis worldwide
•Supportive regulatory scenario provided for the growth of neurotrophic keratitis market by the healthcare agencies throughout the globe
•Recent approval by EMA and priority review designation awarded by the USFDA will help to flourish the Oxervate market for the treatment of neurotrophic keratitis in North America and Europe
Full Report: https://www.credenceresearch.com/sample-request/59723
Medium: https://medium.com/(at)CredenceResearc/neurotrophic-keratitis-market-north-america-is-responsible-for-33-market-share-432cd8d4f1ac

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we''ve manufactured a firm extraordinarily prepared to this task.

Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Email: sales(at)credenceresearch.com


Themen in dieser HerstelerrNews:


Unternehmensinformation / Kurzprofil:



Dies ist eine HerstellerNews von
Credence Research

Leseranfragen:



PresseKontakt / Agentur:



drucken  an Freund senden  Kraftstoffpreise sinken spürbar / Weiterhin Spielraum für Preissenkungen (FOTO)
Grundfos erweitertet das Webinar-Angebot

Bereitgestellt von: satyamspot
Datum: 12.06.2019 - 14:15 Uhr
Sprache: Deutsch
News-ID 1728561
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner: Chris Smith
Stadt: SANJOSE
Telefon: 18003618290

Anmerkungen:


Diese Pressemitteilung wurde bisher 93 mal aufgerufen.


Nach Kategorien:

1. Jahrestagung des Bundesverbandes der Deutschen Kalkindustrie (BVK) (FOTO) 16.06.2019
2. Skalierbare Datenkommunikation mit I/O-Modulen von Acceed 16.06.2019
3. T.D.M. UND EINTRACHT HILDESHEIM RETTEN DIE BIENEN 16.06.2019
4. TOP Abwassertechnik vom Profi 15.06.2019
5. Kältetechnik - im Sommer wichtiger denn je 15.06.2019
6. Halbjahresbilanz Strom: Preise steigen nach Erhöhungswelle weiter (FOTO) 15.06.2019
7. Automotive Smart Antenna Market Business Growth Demand, Strategies, Overview, Competitive Strategies and Forecasts 2018 – 2025 14.06.2019
8. Timing Belt Market Segmentation and Major key Players Analysis: Continental, Borgwarner, Schaffler, SKF, Toyoda, Aisin, Fenner 14.06.2019
9. Für Einsteiger: Kostengünstiges Dusch-WC von VitrA Bad mit dem integrierten Trinkwasserschutz VitrA Aquacare 14.06.2019
10. Frankreich setzt Impulse 14.06.2019
11. iKratos-Sommerfest - Friday for Friends am 26.07 ab 14.00 14.06.2019
12. MorphoSys'' Lizenzpartner Janssen gibt Ergebnisse der Phase 3-Studien mit Guselkumab (Tremfya(R)) bei Erwachsenen mit aktiver psoriatischer Arthritis bekannt 14.06.2019
13. CT für jeden Geschmack - GIFA 2019 14.06.2019
14. Promovieren an der Hochschule Hannover? Graduiertenförderung macht?s möglich 14.06.2019
15. Von CargoPower bis Cargoroo: GreenPack mit wegweisenden Kooperationen auf dem International Cargo Bike Festival in Groningen 14.06.2019
16. Mono-PERC-Halbzellenmodul von Suntech gewinnt die Top Performer Zuverlässigkeits-Scorecard für PV-Module 2019 von DNV GL 14.06.2019
17. Ein erfolgreiches Jahr für die MAPAL Gruppe 14.06.2019
18. Pressekonferenz Forschungsstätte Zoo 14.06.2019
19. Selbstfahrendes Konzeptfahrzeug von Scania: Pendler morgens zur Arbeit, abends nach Hause, tagsüber Waren ausliefern, nachts Müllabfuhr 14.06.2019
20. Spatenstich am Altran Campus Wolfsburg erfolgt 14.06.2019


[ weitere HerstellerNews ][ RSS-Feed ]

Blogverzeichnis - Blog Verzeichnis bloggerei.de